Related Experiment Video

Updated: Jul 6, 2026

Quantification of Reactive Oxygen Species Using 2′,7′-Dichlorofluorescein Diacetate Probe and Flow-Cytometry in Müller Glial Cells
14:25

Quantification of Reactive Oxygen Species Using 2′,7′-Dichlorofluorescein Diacetate Probe and Flow-Cytometry in Müller Glial Cells

Published on: May 13, 2022

The role of Nrf2 in increased reactive oxygen species and DNA damage in prostate tumorigenesis

D A Frohlich1, M T McCabe, R S Arnold

  • 1Department of Urology, UMCC, University of Michigan, Ann Arbor, MI 48109-0944, USA.

Oncogene
|April 1, 2008
PubMed

Insights

The Nrf2-antioxidant pathway is crucial for preventing DNA damage in prostate cancer. Its disruption increases oxidative stress, leading to cellular transformation and tumor development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Oxidative stress from reactive oxygen species (ROS) is a known driver of mutagenic DNA damage and cellular transformation in cancer.
  • The transcription factor Nrf2 (Erythroid 2p45-related factor 2) regulates protective enzymes via the antioxidant-response element (ARE).

Purpose of the Study:

  • To investigate the role of Nrf2 and its associated antioxidant pathway in prostate cancer development.
  • To determine if decreased Nrf2 contributes to increased oxidative stress and DNA damage in prostate cancer.

Main Methods:

  • Analysis of 10 human prostate cancer microarray datasets to assess Nrf2 and glutathione-S-transferase (GST) mu family expression.
  • Utilizing TRAMP transgene and Rb/Nrf2 knockout murine models to study the functional consequences of Nrf2 loss.

Main Results:

  • Nrf2 and GST mu family members were found to be significantly decreased in human prostate cancer samples.
  • Loss of Nrf2 in murine models led to reduced GST expression, elevated ROS levels, and increased DNA damage, promoting tumorigenesis.

Conclusions:

  • Disruption of the Nrf2-antioxidant axis is implicated in increased oxidative stress and DNA damage during prostate cancer initiation.
  • Nrf2 pathway dysfunction is a critical factor in the cellular transformation process within the prostate gland.

Related Concept Videos

Nucleotide Excision Repair01:38

Nucleotide Excision Repair

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair01:08

Nucleotide Excision Repair

Overview
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...